Amantadine.
D000109:Acetylcholine / Q000378:metabolism; D000547:Amantadine / Q000009:adverse effects / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use / Q000633:toxicity; D000818:Animals; D000998:Antiviral Agents / Q000627:therapeutic use; D001480:Basal Ganglia Diseases / Q000188:drug therapy; D001522:Behavior, Animal / Q000187:drug effects; D002395:Catecholamines / Q000378:metabolism; D055598:Chemical Phenomena; D002621:Chemistry; D004285:Dogs; D004298:Dopamine / Q000096:biosynthesis; D004569:Electroencephalography; D006168:Guinea Pigs; D000882:Haplorhini; D006439:Hemodynamics / Q000187:drug effects; D006801:Humans; D007700:Kinetics; D007980:Levodopa / Q000627:therapeutic use; D051379:Mice; D009069:Movement Disorders / Q000188:drug therapy; D010276:Parasympatholytics / Q000627:therapeutic use; D010300:Parkinson Disease / Q000188:drug therapy; D011817:Rabbits; D051381:Rats; D012701:Serotonin / Q000378:metabolism; D014777:Virus Diseases / Q000188:drug therapy
D000998:Antiviral Agents; D002395:Catecholamines; D010276:Parasympatholytics; D012701:Serotonin; D007980:Levodopa; D000547:Amantadine; D000109:Acetylcholine; D004298:Dopamine